相关实验视频
Updated: Feb 4, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
9.3K
割抗性前列腺癌的预后因素 在局部前列腺癌患者中,在回顾性多中心日本队列 (MSUG94) 中进行了机器人辅助激进前列腺切除术
Takeshi Sasaki1, Atsushi Igarashi2, Shin Ebara3
1Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
概括
活检等级5组,淋巴血管侵袭和持续的PSA水平是机器人辅助激进前列腺切除术 (RARP) 后患有抵抗割的前列腺癌 (CRPC) 的关键预测因素. 这些因素有助于有效地分层患者的风险.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 机器人辅助激进前列腺切除术 (RARP) 是前列腺癌 (PCa) 的常见治疗方法.
- 鉴定RARP后割抵抗性前列腺癌 (CRPC) 的风险因素对于患者管理至关重要.
研究的目的:
- 在接受RARP治疗的患者中确定CRPC发展的临床病理风险因素.
- 为CRPC风险分层建立一个预测模型.
主要方法:
- 来自九个日本机构的2825名PCa患者 (2012-2021) 的回顾性分析.
- 排除患有转移性疾病或新辅助/辅助治疗的患者.
- 术后持续性前列腺特异性抗原 (PSA) 的定义为≥0.2 ng/mL.
主要成果:
- 17.4%的人经历了生化复发,0.8%的人发展了CRPC.
- 多变量分析确定了活检等级组5 (aHR 12.74),淋巴血管侵入 (aHR 3.90) 和持久PSA (aHR 8.66) 作为CRPC的独立预测因素.
- 使用这三个因素的模型有效地分层了无CRPC存活率.
结论:
- 活检等级组5,淋巴血管侵袭和持续的PSA水平是CRPC的显著独立预测因素.
- 这种因素的组合可以对接受RARP的患者的CRPC风险进行分层.
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer
54.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.3K
What is Cancer?
14.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
325
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
325
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Skin Cancer
5.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.9K

